Clinical Data

MarginProbe® clinical data debuts in the UK at ORBS by Design 2018

Dr. Jeffrey Falk, board certified Surgical Oncologist at St Johns Hospital in Detroit, recently shared his outstanding results reducing positive margin rates using MarginProbe in lumpectomy at ORBS by Design 2018.

New Research Shows MarginProbe® Reduces Re-Excision Rates for Breast Conserving Surgery by 61%, Giving Renewed Hope to Breast Cancer Patients

A study recently published in the American Journal of Surgery demonstrates that proper use of Dune Medical Devices’ intraoperative margin assessment device, MarginProbe, results in a significant identification of positive margins and a resulting reduction in the re-excision rate for breast conserving surgery - the standard option for patients with early-stage breast cancer.

New Clinical Research Shows MarginProbe® Reduces Re-Excision Rates for Breast Conserving Surgery by 61%

A study recently presented during the 2017 American Society of Breast Surgeons annual meeting demonstrates that proper use of Dune Medical Devices’ intraoperative margin assessment device, MarginProbe, results in a significant difference in the total re-excision rate during breast conserving surgery- the standard option for patients with early stage breast cancer.

Mapping Breast Tissue Types by Miniature Radio-Frequency Near-Field Spectroscopy Sensor in Ex-Vivo Freshly Excised Specimens

MarginProbe® Reduces the Rate of Re-Excision Following Breast Conserving Surgery for Breast Cancer

Routine Use of MarginProbe® in Partial Mastectomy Patients: Three Centers’ Experience, Including Comparison to Historical Re-Excision Rates

The Impact Use of an Intraoperative Margin Assessment Device on Re-Excision Rates

MarginProbe® Device is Able to Reduce Re-Excision Rate of Breast Conserving Surgery in Invasive and Pre-Invasive Breast Cancer Independent from Any Patient or Tumor Related Factors

Combined Experience at Three Breast Centers with Routine Use of an Intraoperative Margin Assessment Device Including Comparison to Historical Re-Excision Rates

Obtaining clear margins following a lumpectomy surgery for breast cancer is an important factor in the treatment of breast cancer while conserving the breast (BCS). Historically, high rates, 26%, of surgical interventions to obtain clear margins have been reported1 .

MarginProbe® Final Results of the German Post-Market Study in Breast Conserving Surgery of Ductal Carcinoma in Situ

A Randomized Prospective Study of Lumpectomy Margin Assessment with Use of MarginProbe® in Patients with Nonpalpable Breast Malignancies

The Impact of Intraoperative Margin Assessment with Adjunctive Use of MarginProbe® vs. Standard of Care, Dependence on Margin Threshold Definition

Detection of Prostate Cancer by Radio-Frequency Near-Field Spectroscopy in Radical Prostatectomy Ex-Vivo Specimens

MarginProbe®: Intraoperative Margin Assessment During Breast Conserving Surgery by Using Radiofrequency Spectroscopy; 2013

Analysis of the Impact of Intraoperative Margin Assessment with Adjunctive Use of MarginProbe® versus Standard of Care on Tissue Volume Removed

Diagnostic Performance of a Novel Device for Real-Time Margin Assessment in Lumpectomy Specimens

A Prospective, Randomized, Controlled, Multicenter Study of a Real-Time, Intraoperative Probe for Positive Margin Detection in Breast-Conserving Surgery.

Margins in Breast-Conserving Therapy: Have We Lost Sight of the Big Picture?

Predictors of Re-Excision Among Women Undergoing Breast-Conserving Surgery for Cancer

Assessment of Lumpectomy Tissue Malignancy Status Using Radio-Frequency (RF) Spectroscopy